Abstract
Purpose:
To evaluate clinical outcomes of silicone tube intubation according to the site of resistance to lacrimal duct probing in complete or partial nasolacrimal duct obstruction patients.
Methods:
This study included 102 eyes of 72 patients who were diagnosed with complete or partial nasolacrimal duct obstruction and who underwent silicone tube intubation. According to the site of resistant to nasolacrimal duct probing, eyes were divided in-to proximal resistance (Group I), distal resistance (Group II) and both side resistance (Group III). The success rate was esti-mated based on functional (symptom relief) and anatomical (normalization of tear meniscus) success.
References
1. Jeffrey JH, Myron Y, Jay SD. The lacrimal drainage system. Ophthalmology. 1999; 7:71–8.
2. Kim JH, Kim JM, Woo KI. The role of dacryocystography in eval-uation of nasolacrimal duct obstruction. J Korean Ophthlamol Soc. 2006; 47:1713–9.
3. Lee SH, Kim SD, Kim JD. Silicone intubation for nasolacrimal duct obstruction in adult. J Korean Ophthalmol Soc. 1997; 38:185–9.
4. Han JS, Park IK, Shin JH. Success rate of silicone intubation be-tween nasolacrimal duct obstruction and stenosis according to dacryocystography. J Korean Ophthalmol Soc. 2013; 54:845–9.
5. Sohn HY, Hur J, Chung EH, Won IG. Clinical observation on silicone intubation in obstruction of lacrimal drainage system. J Korean Ophthalmol Soc. 1990; 31:135–40.
6. Lee HS, Hwang WS, Byun YJ. Clinical results of silicone in-tubation for nasolacrimal duct obstruction in adult. J Korean Ophthalmol Soc. 1997; 38:1926–30.
7. Kim HD, Jeong SK. Silicone tube intubation in acquired nasolacri-mal duct obstruction. J Korean Ophthalmol Soc. 2000; 41:327–31.
8. Park JS, Ha SW, Lew H. Factors affecting the long-term outcome of silicone tube intubation in patients with nasolacrimal duct obstruction. J Korean Ophthalmol Soc. 2011; 52:129–35.
9. Saleh GM, Gauba V, Tsangaris P, Tharmaseelan K. Digital sub-traction dacryocystography and syringing in the management of epiphora. Orbit. 2007; 26:249–53.
10. Gibbs DC. New probe for the intubation of lacrimal canaliculi with silicone rubber tubing. Br J Ophthalmol. 1967; 51:198.
11. Moscato EE, Dolmetsch AM, Silkiss RZ, Seiff SR. Silicone in-tubation for the treatment of epiphora in adults with presumed functional nasolacrimal duct obstruction. Ophthal Plast Reconstr Surg. 2012; 28:35–9.
12. Kim YR, Ahn M. Long term effect of double silicone tube in-tubation for acquired nasolacrimal duct obstruction. J Korean Ophthalmol Soc. 2012; 53:1554–8.
13. Kwon YH, Lee YJ. Long-term results of silicone tube intubation in incomplete nasolacrimal duct obstruction. J Korean Ophthalmol Soc. 2008; 49:190–4.
14. Angrist RC, Dortzbach RK. Silicone intubation for partial and total nasolacrimal duct obstruction in adults. Ophthal Plast Reconstr Surg. 1985; 1:51–4.
15. Lee HS, Lew H, Yun YS. Classification of nasolacrimal duct ob-struction according to dacryocystographic finding and its clinical significance. J Korean Ophthalmol Soc. 2003; 44:1475–82.
Table 1.
Proximal resistance (n = 32) | Distal resistance (n = 33) | Both resistance (n = 37) | p-value | |
---|---|---|---|---|
Age (years) | 64.72 ± 12.55 | 61.24 ± 13.34 | 61.27 ± 13.57 | 0.46∗ |
Sex (Male/female) (n, %) | 9 (28.1)/23 (71.9) | 13 (39.4)/20 (60.6) | 9 (24.3)/28 (75.7) | 0.39† |
Laterality (Rt/Lt) | 16/16 | 11/22 | 18/19 | 0.321† |
Duration of symptom (months) | 32.69 ± 33.38 | 26.06 ± 26.14 | 25.97 ± 40.13 | 0.656∗ |
Duration of intubation (months) | 4.97 ± 1.68 | 5.03 ± 1.49 | 5.03 ± 1.46 | 0.534∗ |
Follow-up (months) | 8.09 ± 3.32 | 8.21 ± 1.52 | 9.38 ± 5.11 | 0.128‡ |
Table 2.
Proximal resistance (n = 32) | Distal resistance (n = 33) | Both resistance (n = 37) | p-value | |
---|---|---|---|---|
Success (n, %) Failure (n, %) | 17 (53.1) 15 (46.9) | 26 (78.8) 7 (21.2) | 10 (27.0) 27 (73.0) | 0.001∗ |
Table 3.
Success | Failure | p-value | ||
---|---|---|---|---|
Complete | Proximal resistance | 4 (66.7) | 2 (33.3) | 0.001∗ |
Distal resistance | 9 (100.0) | 0 (0) | ||
Both resistance | 2 (20.0) | 8 (80.0) | ||
Total | 15 (60.0) | 10 (40.0) | ||
Incomplete | Proximal resistance | 13 (50.0) | 13 (50.0) | 0.014∗ |
Distal resistance | 17 (70.8) | 7 (29.2) | ||
Both resistance | 8 (29.6) | 19 (70.4) | ||
Total | 38 (49.4) | 39 (50.6) |